152 related articles for article (PubMed ID: 16565079)
21. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM
J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530
[TBL] [Abstract][Full Text] [Related]
22. Molecular diversity of hydroxamic acids: part II. Potential therapeutic applications.
Lou B; Yang K
Mini Rev Med Chem; 2003 Sep; 3(6):609-20. PubMed ID: 12871163
[TBL] [Abstract][Full Text] [Related]
23. A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatis.
Engström P; Krishnan KS; Ngyuen BD; Chorell E; Normark J; Silver J; Bastidas RJ; Welch MD; Hultgren SJ; Wolf-Watz H; Valdivia RH; Almqvist F; Bergström S
mBio; 2014 Dec; 6(1):e02304-14. PubMed ID: 25550323
[TBL] [Abstract][Full Text] [Related]
24. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of peptide deformylase inhibitors.
Chen D; Yuan Z
Expert Opin Investig Drugs; 2005 Sep; 14(9):1107-16. PubMed ID: 16144495
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the Protein Phosphatase CppA Alters Development of Chlamydia trachomatis.
Claywell JE; Matschke LM; Plunkett KN; Fisher DJ
J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30038048
[TBL] [Abstract][Full Text] [Related]
28. Regioselectivity in inhibition of peptide deformylase from Haemophilus influenzae by 4- vs 5-azaindole hydroxamic acid derivatives: Biochemical, structural and antimicrobial studies.
Reddi B; Kishor C; Jangam A; Bala S; Rajeswari Batchu U; Gundla R; Addlagatta A
Bioorg Chem; 2022 Nov; 128():106095. PubMed ID: 36049321
[TBL] [Abstract][Full Text] [Related]
29. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach.
Chen D; Hackbarth C; Ni ZJ; Wu C; Wang W; Jain R; He Y; Bracken K; Weidmann B; Patel DV; Trias J; White RJ; Yuan Z
Antimicrob Agents Chemother; 2004 Jan; 48(1):250-61. PubMed ID: 14693547
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
[TBL] [Abstract][Full Text] [Related]
31. Metabolic adaptation of Chlamydia trachomatis to mammalian host cells.
Mehlitz A; Eylert E; Huber C; Lindner B; Vollmuth N; Karunakaran K; Goebel W; Eisenreich W; Rudel T
Mol Microbiol; 2017 Mar; 103(6):1004-1019. PubMed ID: 27997721
[TBL] [Abstract][Full Text] [Related]
32. Chlamydia trachomatis uses host cell dynein to traffic to the microtubule-organizing center in a p50 dynamitin-independent process.
Grieshaber SS; Grieshaber NA; Hackstadt T
J Cell Sci; 2003 Sep; 116(Pt 18):3793-802. PubMed ID: 12902405
[TBL] [Abstract][Full Text] [Related]
33. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
34. EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis.
Subbarayal P; Karunakaran K; Winkler AC; Rother M; Gonzalez E; Meyer TF; Rudel T
PLoS Pathog; 2015 Apr; 11(4):e1004846. PubMed ID: 25906164
[TBL] [Abstract][Full Text] [Related]
35. Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors.
Madison V; Duca J; Bennett F; Bohanon S; Cooper A; Chu M; Desai J; Girijavallabhan V; Hare R; Hruza A; Hendrata S; Huang Y; Kravec C; Malcolm B; McCormick J; Miesel L; Ramanathan L; Reichert P; Saksena A; Wang J; Weber PC; Zhu H; Fischmann T
Biophys Chem; 2002 Dec; 101-102():239-47. PubMed ID: 12488004
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analyses and inhibition studies reveal novel features in peptide deformylase 1 from Trypanosoma cruzi.
Rodrígues-Poveda CA; Pérez-Moreno G; Vidal AE; Urbina JA; González-Pacanowska D; Ruiz-Pérez LM
Mol Biochem Parasitol; 2012; 182(1-2):83-7. PubMed ID: 22209909
[TBL] [Abstract][Full Text] [Related]
37. Anti-chlamydial activities of cell-permeable hydrophobic dipeptide-containing derivatives.
Itoh R; Soejima T; Hiromatsu K
J Infect Chemother; 2019 Dec; 25(12):987-994. PubMed ID: 31230920
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group.
Smith HK; Beckett RP; Clements JM; Doel S; East SP; Launchbury SB; Pratt LM; Spavold ZM; Thomas W; Todd RS; Whittaker M
Bioorg Med Chem Lett; 2002 Dec; 12(24):3595-9. PubMed ID: 12443784
[TBL] [Abstract][Full Text] [Related]
39. Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development.
Hall JV; Sun J; Slade J; Kintner J; Bambino M; Whittimore J; Schoborg RV
Front Cell Infect Microbiol; 2014; 4():158. PubMed ID: 25414835
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a human peptide deformylase: implications for antibacterial drug design.
Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
